Negotiations are set to resume on Dec. 9 as the German car maker faces weak demand for electric vehicles and competition from lower-cost Chinese competitors.
Related Posts
Sanofi in Talks to Sell Controlling Stake in Consumer Health Arm to CD&R
The French drugmaker said the negotiations are for a potential sale of a 50% controlling stake in Opella.
Stellantis Shifts Focus to Efficient Investments, Returns
- staff
- June 13, 2024
- 0
The maker of Jeep, Dodge and a dozen other brands said it will set a liquidity target of 25%-30% of revenue in the medium term […]
The Airline Industry’s Biggest Winners Are Betting You’ll Pay to Fly in Style
United and Delta dominate industry profits by promoting premium travel options like carved up cabins and luxe lounges